A Novel “Three‐in‐One” Copper‐Based Metal‐Organic Framework Nanozyme Eradicates Colorectal Cancer and Overcomes Chemoresistance for Tumor Therapy
Authors:
Open Access
- 4 December 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 12 (6) , e2413422
Abstract
Despite considerable advancements in the treatment of colorectal cancer (CRC), the overall survival rate for patients with advanced CRC remains below 50%, primarily due to challenges posed by drug resistance and metastasis. Here, a novel “Three‐in‐One” Cu‐based metal‐organic framework nanozyme with peroxidase‐like (POD‐like) activity has been successfully developed, aiming to promote CRC cell death by dual targeting of oxidative stress and copper ion homeostasis, which could promote CRC cell death via apoptosis and cuproptosis, and facilitate hypoxia‐inducible factor 1α (HIF‐1α) degradation, leading to the reversal of chemoresistance in tumor therapy. These nanozymes, composed of copper and 2‐propylimidazole (Cu‐PrIm), feature a distorted Cu‐N4 catalytic active center that mimics natural enzyme structures consisting of copper and histidine residues, endowing them with enzyme‐like activities. The antitumor efficacy of Cu‐PrIm nanozymes is validated in various in vivo models of CRC. Especially Cu‐PrIm nanozymes exhibit excellent biocompatibility, biodegradability, and a tolerable toxicity profile in mouse models, making them a strong candidate for clinical translation. Taken together, the study introduces a novel therapeutic paradigm in CRC treatment by targeting these vulnerabilities and leveraging the potential using “Three‐in‐One” Cu‐PrIm nanozymes to address multiple pathways simultaneously.Keywords
Funding Information
- National Natural Science Foundation of China (82303242, 82270914)
- Postdoctoral Innovation Project of Shandong Province (SDCX‐ZG‐202400075)
This publication has 65 references indexed in Scilit:
- Regulating Reactive Oxygen Intermediates of Fe−N−C SAzyme via Second‐Shell Coordination for Selective Aerobic Oxidation ReactionsAngewandte Chemie International Edition, 2024
- NanozymesAdvanced Materials, 2024
- Self‐Reinforced Bimetallic Mito‐Jammer for Ca 2+ Overload‐Mediated Cascade Mitochondrial Damage for Cancer Cuproptosis SensitizationAdvanced Science, 2024
- Metal–Organic Frameworks Meet Polymers: From Synthesis Strategies to Healthcare ApplicationsAdvanced Materials, 2023
- Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer ImmunotherapyAdvanced Materials, 2023
- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2022
- Tumor Diagnosis and Therapy Mediated by Metal Phosphorus‐Based NanomaterialsAdvanced Materials, 2021
- Antitumor Agents Based on Metal–Organic FrameworksAngewandte Chemie International Edition, 2021
- GSH‐Depleted Nanozymes with Hyperthermia‐Enhanced Dual Enzyme‐Mimic Activities for Tumor Nanocatalytic TherapyAdvanced Materials, 2020
- Recent Progress in Ferroptosis Inducers for Cancer TherapyAdvanced Materials, 2019